Top

SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma

Journals by subject

Unlock free access to practice-relevant journal articles

Join our community of medical professionals and register now to access a handpicked selection of journal articles from Springer's Medical portfolio.

Editor's Choice | Journals

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Latest Journal Issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Looking for something specific?

Find articles from over 500 clinical journals from Springer with the search function.

Latest issues in Internal Medicine

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Latest issues in Cardiology

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Latest issues in Diabetes & Endocrinology

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Latest issues in Neurology

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Latest issues in Oncology

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Latest issues in Pediatrics

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Latest issues in Respiratory Medicine

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

About journals on Springer Medicine

The range of medical journals on Springer Medicine is extremely diverse. It includes the current editions and archives of around 500 English-language journals from almost all medical disciplines published by Springer.

The specialist literature is usually available both online in full text and as a PDF for download. The online view is optimized in such a way that the specialist texts can be read comfortably on all screen sizes, from desktops to tablets to smartphones. We also include features to support your use of the journals for your research, such as bookmark setting.

Whether you’re interested in internal medicine, surgery, general medicine, gynecology, orthopedics, neurology, or pediatrics, there are excellent journals in almost every subject area, such as the BMC Series, Diabetologia, Breast Cancer Research, Current Obesity Reports, CNS Drugs and many others, all of which are an integral part of the everyday life of doctors across Europe.

The breadth of content from this suite of journals allows the Springer Medicine team to collect and deliver broad-ranging content across the full spectrum of medical knowledge, with a special focus on topics highlighted by these leading journals and their editorial boards and specialist authors. This guarantees a high quality of content and ensures that our readers are offered the most relevant topics in their respective specialist area.

Our experienced clinical content managers constantly monitor the needs of medical professionals to provide up-to-date reports from international congresses, expert interviews, and a range of digestible content on emerging topics in the field of medicine.

BMC Cancer

Published in:

Open Access 01-12-2024 | Research

SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma

Authors: Liming Zhang, Shaoqiang Wang, Lina Wang

Published in: BMC Cancer | Issue 1/2024

Abstract

Background

Esophageal carcinoma (ESCA) ranks among the most prevalent malignant tumors globally. Despite significant advancements in treatment options and improved patient outcomes, the 5-year survival rate remains unsatisfactory. The spindle and kinetochore associated complex subunit 1/2/3 (SKA1/2/3) attached to the kinetochore (KT) in the metaphase of mitosis are implicated in the occurrence and development of various tumors. However, the expression patterns, diagnostic significance and prognostic implications of SKA1/2/3 in ESCA have not been comprehensively determined.

Methods

TCGA, UALCAN, Kaplan-Meier Plotter, and TIMER databases were leveraged to dissect the expression patterns, prognostic implications and diagnostic value of SKA1/2/3 in ESCA patients, as well as to investigate the potential regulatory mechanism of SKA1/2/3 in the onset and progression of ESCA.

Results

In ESCA, SKA1/2/3 exhibited substantial expression, with higher levels relating significantly with clinicopathological features and patient prognosis. Enrichment analysis of genes co-expressed with SKA1/2/3 highlighted their involvement in the cell cycle, DNA replication and p53 signaling pathway. Protein-protein interaction (PPI) analysis identified ten hub genes that were not only markedly upregulated but also portended a poor prognosis in ESCA. Additionally, immune infiltration assays uncovered a significant link between SKA1/2/3 expression and the immune cell infiltration within ESCA. Silencing of SKA1/2/3 significantly suppresses cell proliferation and migration, while concurrently promoting apoptosis in ESCA cells.

Conclusions

SKA1/2/3 may serve as promising biomarkers for the prognosis and diagnosis of ESCA, which holds promise as a novel therapeutic target for the disease.

Available only for authorised users

Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381–7.CrossRefPubMed

Peng Z, Liu XY, Cheng Z, Kai W, Song Z. Comprehensive analysis of a new immune-related prognostic signature for esophageal cancer and its correlation with infiltrating immune cells and target genes. Ann Transl Med. 2021;9(20):1576.CrossRefPubMedPubMedCentral

Mao YS, Gao SG, Wang Q, Shi XT, Li Y, Gao WJ, Guan FS, Li XF, Han YT, Liu YY et al. Analysis of a registry database for esophageal cancer from high-volume centers in China. Dis Esophagus 2020, 33(8).

Gaitanos TN, Santamaria A, Jeyaprakash AA, Wang B, Conti E, Nigg EA. Stable kinetochore-microtubule interactions depend on the Ska complex and its new component Ska3/C13Orf3. Embo j. 2009;28(10):1442–52.CrossRefPubMedPubMedCentral

Hanisch A, Silljé HH, Nigg EA. Timely anaphase onset requires a novel spindle and kinetochore complex comprising Ska1 and Ska2. Embo j. 2006;25(23):5504–15.CrossRefPubMedPubMedCentral

Tian F, Xing X, Xu F, Cheng W, Zhang Z, Gao J, Ge J, Xie H. Downregulation of SKA1 gene expression inhibits cell growth in human bladder Cancer. Cancer Biother Radiopharm. 2015;30(7):271–7.PubMed

Dong C, Wang XL, Ma BL. Expression of Spindle and Kinetochore-Associated Protein 1 Is Associated with Poor Prognosis in Papillary Thyroid Carcinoma. Dis Markers 2015, 2015:616541.

Wang D, Suo YJ, Gong L, Lv SQ. SKA2 promotes proliferation and invasion of hepatocellular carcinoma cells via activating the β-catenin signaling pathway. Neoplasma. 2020;67(4):743–50.CrossRefPubMed

Gao W, Zhang Y, Luo H, Niu M, Zheng X, Hu W, Cui J, Xue X, Bo Y, Dai F, et al. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis. Cell Death Dis. 2020;11(10):919.CrossRefPubMedPubMedCentral

10.

Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S. UALCAN: a portal for facilitating Tumor Subgroup Gene expression and survival analyses. Neoplasia. 2017;19(8):649–58.CrossRefPubMedPubMedCentral

11.

Nagy Á, Munkácsy G, Győrffy B. Pancancer survival analysis of cancer hallmark genes. Sci Rep. 2021;11(1):6047.CrossRefPubMedPubMedCentral

12.

von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31(1):258–61.CrossRef

13.

Lopes CT, Franz M, Kazi F, Donaldson SL, Morris Q, Bader GD. Cytoscape web: an interactive web-based network browser. Bioinformatics. 2010;26(18):2347–8.CrossRefPubMedPubMedCentral

14.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: a web server for Comprehensive Analysis of Tumor-infiltrating Immune cells. Cancer Res. 2017;77(21):e108–10.CrossRefPubMedPubMedCentral

15.

Sivakumar S, Janczyk P, Qu Q, Brautigam CA, Stukenberg PT, Yu H, Gorbsky GJ. The human SKA complex drives the metaphase-anaphase cell cycle transition by recruiting protein phosphatase 1 to kinetochores. Elife. 2016;5:e12902.

16.

Wang X, Zeng Y, Zhou M, Zhang X, Xu A, Lin J, Wu Z, Xie C, Luo J, Ding S, et al. SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways. Cancer Cell Int. 2019;19:324.CrossRefPubMedPubMedCentral

17.

Hou Y, Wang Z, Huang S, Sun C, Zhao J, Shi J, Li Z, Wang Z, He X, Tam NL, et al. SKA3 promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma. Cell Death Dis. 2019;10(12):929.CrossRefPubMedPubMedCentral

18.

Shen L, Yang M, Lin Q, Zhang Z, Miao C, Zhu B. SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer. Oncol Rep. 2016;35(5):2561–8.CrossRefPubMedPubMedCentral

19.

Arai T, Okato A, Kojima S, Idichi T, Koshizuka K, Kurozumi A, Kato M, Yamazaki K, Ishida Y, Naya Y, et al. Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma. Cancer Sci. 2017;108(10):2088–101.CrossRefPubMedPubMedCentral

20.

Li T, Liu X, Xu B, Wu W, Zang Y, Li J, Wei L, Qian Y, Xu H, Xie M, et al. SKA1 regulates actin cytoskeleton remodelling via activating Cdc42 and influences the migration of pancreatic ductal adenocarcinoma cells. Cell Prolif. 2020;53(4):e12799.CrossRefPubMedPubMedCentral

21.

Wang Y, Zhang C, Mai L, Niu Y, Wang Y, Bu Y. PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer. BMB Rep. 2019;52(2):157–62.CrossRefPubMedPubMedCentral

22.

Su H, Ren F, Jiang H, Chen Y, Fan X. Upregulation of microRNA-520a-3p inhibits the proliferation, migration and invasion via spindle and kinetochore associated 2 in gastric cancer. Oncol Lett. 2019;18(3):3323–30.PubMedPubMedCentral

23.

Tang D, Zhao X, Zhang L, Wang Z, Wang C. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses. J Cell Biochem. 2019;120(6):9522–31.CrossRefPubMed

24.

Zhang C, Zhao S, Tan Y, Pan S, An W, Chen Q, Wang X, Xu H. The SKA3-DUSP2 Axis promotes gastric Cancer Tumorigenesis and epithelial-mesenchymal transition by activating the MAPK/ERK Pathway. Front Pharmacol. 2022;13:777612.CrossRefPubMedPubMedCentral

25.

Chen C, Guo Q, Song Y, Xu G, Liu L. SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma. Transl Lung Cancer Res. 2020;9(2):218–31.CrossRefPubMedPubMedCentral

26.

Daum JR, Wren JD, Daniel JJ, Sivakumar S, McAvoy JN, Potapova TA, Gorbsky GJ. Ska3 is required for spindle checkpoint silencing and the maintenance of chromosome cohesion in mitosis. Curr Biol. 2009;19(17):1467–72.CrossRefPubMedPubMedCentral

27.

Theis M, Slabicki M, Junqueira M, Paszkowski-Rogacz M, Sontheimer J, Kittler R, Heninger AK, Glatter T, Kruusmaa K, Poser I, et al. Comparative profiling identifies C13orf3 as a component of the Ska complex required for mammalian cell division. Embo j. 2009;28(10):1453–65.CrossRefPubMedPubMedCentral

28.

Wu CX, Wang XQ, Chok SH, Man K, Tsang SHY, Chan ACY, Ma KW, Xia W, Cheung TT. Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma. Theranostics. 2018;8(14):3737–50.CrossRefPubMedPubMedCentral

29.

Tang J, Pan H, Wang W, Qi C, Gu C, Shang A, Zhu J. MiR-495-3p and mir-143-3p co-target CDK1 to inhibit the development of cervical cancer. Clin Transl Oncol. 2021;23(11):2323–34.CrossRefPubMed

30.

Tang Q, Li W, Zheng X, Ren L, Liu J, Li S, Wang J, Du G. MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma. Signal Transduct Target Ther. 2020;5(1):279.CrossRefPubMedPubMedCentral

31.

Wang X, Xiao H, Wu D, Zhang D, Zhang Z. Mir-335-5p regulates cell cycle and metastasis in Lung Adenocarcinoma by Targeting CCNB2. Onco Targets Ther. 2020;13:6255–63.CrossRefPubMedPubMedCentral

32.

Qian X, Song X, He Y, Yang Z, Sun T, Wang J, Zhu G, Xing W, You C. CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients. Biomed Pharmacother. 2015;74:222–7.CrossRefPubMed

33.

Silva Cascales H, Burdova K, Middleton A, Kuzin V, Müllers E, Stoy H, Baranello L, Macurek L, Lindqvist A. Cyclin A2 localises in the cytoplasm at the S/G2 transition to activate PLK1. Life Sci Alliance 2021, 4(3).

34.

Zhang QH, Yuen WS, Adhikari D, Flegg JA, FitzHarris G, Conti M, Sicinski P, Nabti I, Marangos P, Carroll J. Cyclin A2 modulates kinetochore-microtubule attachment in meiosis II. J Cell Biol. 2017;216(10):3133–43.CrossRefPubMedPubMedCentral

35.

Yang F, Hu Y, Liu HX, Wan YJ. MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor. J Biol Chem. 2015;290(10):6507–15.CrossRefPubMedPubMedCentral

36.

Li T, Liu D, Li C, Ru L, Wang X. Silencing of LncRNA AFAP1-AS1 inhibits cell proliferation in oral squamous Cancer by suppressing CCNA2. Cancer Manag Res. 2021;13:7897–908.CrossRefPubMedPubMedCentral

37.

Li H, Weng Y, Wang S, Wang F, Wang Y, Kong P, Zhang L, Cheng C, Cui H, Xu E, et al. CDCA7 facilitates Tumor Progression by directly regulating CCNA2 expression in esophageal squamous cell carcinoma. Front Oncol. 2021;11:734655.CrossRefPubMedPubMedCentral

38.

Deng H, Cheng Y, Guo Z, Zhang F, Lu X, Feng L, Wang X, Xu Z. Overexpression of CyclinA2 ameliorates hypoxia-impaired proliferation of cardiomyocytes. Exp Ther Med. 2014;8(5):1513–7.CrossRefPubMedPubMedCentral

39.

Zhong C, Han Y, Ma J, Zhang X, Sun M, Wang Y, Chen J, Mi W, Xu X, Qiu J. Viral-mediated expression of c-Myc and cyclin A2 induces cochlear progenitor cell proliferation. Neurosci Lett. 2015;591:93–8.CrossRefPubMed

40.

Zhou X, Yuan Y, Kuang H, Tang B, Zhang H, Zhang M. BUB1B (BUB1 mitotic checkpoint Serine/Threonine kinase B) promotes lung adenocarcinoma by interacting with zinc finger protein ZNF143 and regulating glycolysis. Bioengineered. 2022;13(2):2471–85.CrossRefPubMedPubMedCentral

Title: SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma
Authors: Liming Zhang
Shaoqiang Wang
Lina Wang
Publication date: 01-12-2024
Publisher: BioMed Central
Published in: BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-024-13257-8

A randomised study to evaluate the potential added value of shared meditation involving people with cancer, health professionals and third persons compared to meditation conducted with patients only: design of the Implic-2 protocol

Open Access
Mindfulness
Study Protocol

Retraction Note: Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145

Open Access
Gastric Cancer
Retraction Note

A nomogram based on peripheral lymphocyte for predicting 8-year survival in patients with prostate cancer: a single-center study using LASSO-cox regression

Open Access
Prostate Cancer
Original Research

Amputation in patients with extremity soft tissue sarcoma: the experience of an East Asian referral center

Open Access
Soft Tissue Sarcoma
Original Research

Association of telomerase reverse transcriptase gene rs10069690 variant with cancer risk: an updated meta-analysis

Open Access
Breast Cancer
Original Research

Pediatric pleuropulmonary blastoma: analysis of four cases

Open Access
Pneumothorax
Original Research

Keynote series | Spotlight on menopause

Springer Medicine

SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma

Unlock free access to practice-relevant journal articles

Looking for something specific?

About journals on Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content